Hacker News Reader

It impacts him at the margin. More eyeballs on articles like this one mean a faster market response and more patients doing a little extra digging to find fair treatment for their ailment. He also wouldn't want this article to come up as the top result for his name. A shady business reputation makes it harder to find investors, partners and employees.

View on HN

Yes, in the short-term, being up written up in the NY times for what they are is the best way to deal with most egregious unethical behavior from scum like Turing Pharmaceuticals. It will be interesting to see if the prices goes back down as a result of this exposure.

Sadly, that can't prevent pharma companies from arbitrarily jacking up prices less dramatically on many other drugs and going "under the radar" as far as public outrage is concerned. For that, you need careful and assiduous regulation. But in an era where people run companies that do real things like a hedge fund, I am doubtful things will get better anytime soon.

For that, you need careful and assiduous regulation.

Do you have any particular proposal to solve the problem? Saying "regulate!" doesn't help unless you can provide specifics.

Reply on news.ycombinator.com